Pds biotech to host oncology r&d day on june 16, 2021

Florham park, n.j., june 01, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies based on the company's proprietary versamune® t-cell activating technology, today announced it will host an oncology r&d day for analysts, investors, and the scientific community from 8:00 – 10:00 am et on wednesday, june 16th.
PDSB Ratings Summary
PDSB Quant Ranking